-+ 0.00%
-+ 0.00%
-+ 0.00%

Eikon to present six abstracts at ASCO annual meeting

PUBT·05/21/2026 21:12:03
Listen to the news
Eikon to present six abstracts at ASCO annual meeting
  • Eikon Therapeutics will present six oncology abstracts at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago starting May 29, 2026.
  • Data presentations will cover EIK1001 in first-line stage 4 non-small cell lung cancer, including combination regimens with pembrolizumab.
  • Additional updates will include EIK1003 results in advanced solid tumors, including combination work with paclitaxel, alongside early clinical progress for WRN inhibitor candidate EIK1005.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eikon Therapeutics Inc. published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.